Composite outcomes of drug-coated balloon using in left main bifurcation lesions: a systematic review.

ABSTRACT:

Background

Left main coronary bifurcation lesions account for 50% of left main coronary artery disease cases. Although a drug-coated balloon (DCB) has the advantages of immediate release of the drug to the arterial wall and no remaining struts, there is no conclusive evidence to support DCB use.

Methods & results

We conducted a systematic review in compliance with the Preferred Reporting Items for Systematic Review and Meta-Analyses (PRISMA) statement. Eighteen retrospective studies and two prospective studies in which left main bifurcation lesions were treated with DCBs were included in our qualitative analysis. The studies were divided into two groups according to the type of DCB used: DCB only and DCB + stent. At the midterm follow-up, the use of DCBs had noninferior or e

SUBMITTER: Cheng Y 

PROVIDER: S-EPMC11672355 | biostudies-literature | 2024 Nov

REPOSITORIES: biostudies-literature